These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4959763)

  • 21. [Restoration of drug sensitivity in Mycobacterium tuberculosis to streptomycin and isoniazid during treatment with preparations of the 1st series].
    Rudoĭ NM; Utkin VV; Fedorova IE; Afanas'eva IuP
    Antibiotiki; 1970 Apr; 15(4):355-7. PubMed ID: 4993044
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug sensitivity patterns of Mycobacterium tuberculosis isolated in Addis Ababa.
    Lemma E; Valdivia Alvarez JA; Gebre-Tsadik G; Echemendia Font M
    Ethiop Med J; 1984 Apr; 22(2):93-6. PubMed ID: 6202516
    [No Abstract]   [Full Text] [Related]  

  • 23. [Kanamycin dependence of Mycobacterium tuberculosis in a patient with fibro-cavernous tuberculosis].
    Gapon ES; Kasatkina OK
    Probl Tuberk; 1973; 51(10):86-7. PubMed ID: 4206105
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effectiveness of the surgical treatment of patients with pulmonary tuberculosis and multidrug resistance of its causative agent].
    Shaĭkhaev AIa; Naumov VN
    Probl Tuberk; 2000; (4):24-6. PubMed ID: 10981427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mycobacterium tuberculosis resistant drugs and their effect on guinea pigs inoculated with a mixture of sensitive and resistant M. tuberculosis].
    Belogurova VP
    Antibiotiki; 1971 May; 16(5):429-33. PubMed ID: 5002222
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of pH of the medium and other factors on the selection of isoniazid-resistant forms of M. tuberculosis].
    Dolzhanskiĭ VM
    Probl Tuberk; 1975; (9):68-71. PubMed ID: 6956
    [No Abstract]   [Full Text] [Related]  

  • 27. [Streptomycin and isoniazid resistance of strains of Mycobacterium tuberculosis isolated in Catania].
    Placenti A
    Lotta Tuberc; 1969; 39(4):264-74. PubMed ID: 4997375
    [No Abstract]   [Full Text] [Related]  

  • 28. Implications of emerging isoniazid resistance to Mycobacterium tuberculosis in Korea.
    Hong YP; Jin BW; Kim SJ
    Aviat Space Environ Med; 1988 Feb; 59(2):185. PubMed ID: 3125824
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of hypoglycemic drugs on results of treatment with nicotinic acid hydrazide in experimental tuberculosis in guinea pigs, caused by Mycobacterium tuberculosis of low resistance to INH].
    Kulig A
    Patol Pol; 1968; 19(1):237-41. PubMed ID: 4968014
    [No Abstract]   [Full Text] [Related]  

  • 30. [Antibacterial effect of Soliutizon].
    Pershin GN; Makeeva OO
    Probl Tuberk; 1966; 44(7):63-7. PubMed ID: 4969291
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of rifampicin on the intra- and extracellularly located Mycobacterium tuberculosis].
    Pavlov EP; Tushov EG; Kotliarov LM
    Probl Tuberk; 1974; (12):64-7. PubMed ID: 4216898
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of different isoniazid concentrations on the Mycobacterium tuberculosis variant highly resistant to the preparation].
    Bondarev IM; Dolgaia TM
    Probl Tuberk; 1980 Aug; (8):65-9. PubMed ID: 6773048
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on atypical mycobacteria. X. Experimental approach to the etiology of atypical mycobacteriosis.
    Ogawa T; Motomura K
    Kekkaku; 1971 Sep; 46(9):365-70. PubMed ID: 5122006
    [No Abstract]   [Full Text] [Related]  

  • 34. KatG sequence deletion is not the major cause of isoniazid resistance in Japanese and Yemeni Mycobacterium tuberculosis isolates.
    Goto M; Oka S; Tachikawa N; Kitada K; Wada M; Abe C; Shimada K; Kimura S
    Mol Cell Probes; 1995 Dec; 9(6):433-9. PubMed ID: 8808314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Occurrence and clinical importance of drug resistance of Mycobacterium tuberculosis in patients with pulmonary tuberculosis].
    Kuznetsova EE
    Probl Tuberk; 1970; 48(9):39-43. PubMed ID: 4996495
    [No Abstract]   [Full Text] [Related]  

  • 36. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA; Ursov IG
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of acridine compounds on stopping the development of drug resistance in Mycobacterium tuberculosis (an experimental study)].
    Efremova IIa; Il'ina TB; Vishnevskiĭ BI; Vavilin GI
    Probl Tuberk; 1977 Sep; (9):61-4. PubMed ID: 411125
    [No Abstract]   [Full Text] [Related]  

  • 38. [Resistance of Mycobacterium tuberculosis isolated from guinea pigs infected with a mixture of strains sensitive and resistant to tubazid].
    Belogurova VP
    Probl Tuberk; 1967; 45(5):81-5. PubMed ID: 4979497
    [No Abstract]   [Full Text] [Related]  

  • 39. Increasing drug resistance of Mycobacterium tuberculosis isolates in Ontario, Canada, 1987-1998.
    Remis RS; Jamieson F; Chedore P; Haddad A; Vernich L
    Clin Infect Dis; 2000 Aug; 31(2):427-32. PubMed ID: 10987700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antitubercular effect of capreomycin in vitro].
    Janowiec M
    Gruzlica; 1969 Jul; 37(7):629-35. PubMed ID: 4981783
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.